OZSTAR THERAPEUTICS

At OzStar Therapeutics we are committed to contributing to the scientific community we engage with. Our clinical trial results were presented at the European Association for the Study of Diabetes (EASD). Subsequently, these results were peer-reviewed and published in an international journal. The OzStar team has also published a review article describing the benefits of the adjunct intake of prebiotics such as Agulcator® in medicinal therapies. OzStar CEO has since been invited as a keynote speaker at several related international conferences... OzStar Therapeutics manufactured OZ101 tablets (a tableted form of Agulcator®) and used in a phase 2 clinical trial... OzStar Therapeutics conducted several long-term clinical case studies and an Australian Government-backed clinical trial that showed an effective adjunct to sulphonylurea treated type 2 diabetics.

Also known as: OzStar Therapeutics Pty Ltd

Primary location: Hills Australia